IMUGENE LIMITED - Announcements

3.64%

26.5¢

Market Cap $76.45M

Healthcare Biotechnology

Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing... Imugene Limited is a clinical-stage immune-oncology company. It is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its platform technology seeks to harness and promote the body’s immune system against cancerous tumors. Its product pipeline includes an off-the-shelf (allogeneic) cell therapy CAR T drug Azer-Cel (azercabtagene zapreleucel) which targets CD19 to attack blood cancer. Its pipeline includes an Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard of care drugs and immunotherapies. Its lead candidate is a chimeric vaccinia (pox) virus known as CF33, which is a combination of genomic sequences from multiple vaccinia virus strains to generate a new, safer and more potent virus. Its Chimeric antigen receptor (CAR)-engineered T cells (CAR T) are T cells redirected against tumors through engineered expression of CARs. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

IMU	Investor Presentation		09/01/17	11.86MB	Share
IMU	Investor Newsletter		20/12/16	10.13MB	Share
IMU	Imugene progresses mimotope platform	PRICE SENSITIVE	19/12/16	239.63KB	Share
IMU	Response to ASX Aware Query	PRICE SENSITIVE	16/12/16	202.23KB	Share
IMU	Response to ASX Price Query	PRICE SENSITIVE	13/12/16	412.71KB	Share
IMU	Acquisition of immuno-oncology technology	PRICE SENSITIVE	13/12/16	83.3KB	Share
IMU	Imugene Corporate Presentation		02/12/16	7.35MB	Share
IMU	Response to ASX Price Query	PRICE SENSITIVE	25/11/16	172.93KB	Share
IMU	Leslie Chong Appointed Chief Executive Officer	PRICE SENSITIVE	21/11/16	174.4KB	Share
IMU	Change of Director's Interest Notice		09/11/16	135.59KB	Share
IMU	Change in substantial holding		07/11/16	144.93KB	Share
IMU	Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study	PRICE SENSITIVE	07/11/16	179.34KB	Share
IMU	Ceasing to be a substantial holder		04/11/16	135.03KB	Share
IMU	Appendix 3B, 708A Notice & Listing Rule 3.10.5A information-IMU.AX		03/11/16	370.49KB	Share
IMU	Appendix 3B, 708A Notice & Listing Rule 3.10.5A information		03/11/16	370.49KB	Share
IMU	Results of Meeting-IMU.AX		02/11/16	70.77KB	Share
IMU	AGM Presentation-IMU.AX		02/11/16	1.4MB	Share
IMU	Director Resignation - Final Director Interest Notice-IMU.AX		31/10/16	412.74KB	Share
IMU	Becoming a substantial holder-IMU.AX		31/10/16	141.11KB	Share
IMU	Appendix 4C - quarterly-IMU.AX	PRICE SENSITIVE	27/10/16	296.35KB	Share
IMU	Appendix 3B-IMU.AX		27/10/16	290.29KB	Share
IMU	Imugene Share Placement raises $3.2 million-IMU.AX	PRICE SENSITIVE	21/10/16	170.52KB	Share
IMU	Trading Halt-IMU.AX	PRICE SENSITIVE	19/10/16	268.86KB	Share
IMU	Notice of Annual General Meeting/Proxy Form-IMU.AX		30/09/16	1.04MB	Share
IMU	Appendix 4G-IMU.AX		28/09/16	312.86KB	Share
IMU	Annual Report to shareholders-IMU.AX		28/09/16	586.04KB	Share
IMU	Imugene receives $1.3m R&D Tax Refund-IMU.AX	PRICE SENSITIVE	22/09/16	152.62KB	Share
IMU	Imugene successfully completes preclinical animal studies-IMU.AX	PRICE SENSITIVE	20/09/16	56.94KB	Share
IMU	Preliminary Final Report-IMU.AX	PRICE SENSITIVE	30/08/16	123.14KB	Share
IMU	Imugene Final Cancer Vaccine Doses Delivered to GMP Depot-IMU.AX	PRICE SENSITIVE	30/08/16	61.47KB	Share
IMU	Imugene Receives Approval to Start Gastric Cancer Study-IMU.AX	PRICE SENSITIVE	22/08/16	173.4KB	Share
IMU	Imugene Receives Institutional Review Board approval-IMU.AX	PRICE SENSITIVE	11/08/16	44.54KB	Share
IMU	Appendix 4C - quarterly-IMU.AX	PRICE SENSITIVE	29/07/16	392.39KB	Share
IMU	Imugene Receives Institutional Review Board Approval-IMU.AX	PRICE SENSITIVE	11/07/16	268.17KB	Share
IMU	Becoming a substantial holder-IMU.AX		06/07/16	309.56KB	Share
IMU	Ceasing to be a substantial holder-IMU.AX		15/06/16	270.23KB	Share
IMU	Corporate Development Update-IMU.AX		27/05/16	115.75KB	Share
IMU	Appendix 4C - quarterly-IMU.AX	PRICE SENSITIVE	29/04/16	689.56KB	Share
IMU	Regulatory package submission for Her-Vaxx in Hong Kong-IMU.AX	PRICE SENSITIVE	21/04/16	140.36KB	Share
IMU	Shareholder Newsletter-IMU.AX		13/04/16	809.32KB	Share
IMU	Dr Yelena Janjigian appointed as SAB member-IMU.AX		12/04/16	120.26KB	Share
IMU	Manufacturing Update	PRICE SENSITIVE	07/03/16	50.79KB	Share
IMU	Imugene Results for December Half Year		29/02/16	140.69KB	Share
IMU	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/16	695.7KB	Share
IMU	Imugene to present at the RedChip Global Online Conference		10/02/16	126.84KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/16	153.95KB	Share
IMU	Partnership to Develop Mimotope Immuno-Oncology Platform	PRICE SENSITIVE	20/01/16	56.12KB	Share
IMU	Final Director's Interest Notice (OB)		18/01/16	35.16KB	Share
IMU	Noble Financial Capital Markets Investor Presentation		15/01/16	197.88KB	Share
IMU	Biotech Showcase Presentation		11/01/16	6.03MB	Share
IMU	Initial Director's Interest Notice AU		07/01/16	235.15KB	Share
IMU	Dr. Anton Uvarov appointed Non-Executive Director		05/01/16	117.38KB	Share
IMU	Stuart Roberts named as Head of Corporate Development		04/01/16	49.97KB	Share
IMU	Imugene to present at the 2016 Biotech Showcase		22/12/15	38.65KB	Share
IMU	Imugene key HER-Vaxx patent granted in Europe	PRICE SENSITIVE	18/12/15	45.22KB	Share
IMU	Director Resignation - Mr. Otto Buttula		17/12/15	110.9KB	Share
IMU	Change of Director's Interest Notice (PH)		14/12/15	141.15KB	Share
IMU	Novotech appointed Contract Research Organisation	PRICE SENSITIVE	14/12/15	48.37KB	Share
IMU	Change of Director's Interest Notice (OB)		11/12/15	139.52KB	Share
IMU	Change of Director's Interest Notice (PH)		08/12/15	141.52KB	Share
IMU	Change of Director's Interest Notice (OB)		30/11/15	139.53KB	Share
IMU	Change of Director's Interest Notice (OB)		23/11/15	140.16KB	Share
IMU	Change of Director's Interest Notice (PH)		13/11/15	137.1KB	Share
IMU	Change of Director's Interest Notice (OB)		13/11/15	136.62KB	Share
IMU	Change of Director's Interest Notice (CW)		13/11/15	136.41KB	Share
IMU	Appendix 3B		09/11/15	293.08KB	Share
IMU	Change of Director's Interest Notice (AH)		02/11/15	139.98KB	Share
IMU	Change of Director's Interest Notice (OB)		30/10/15	135.94KB	Share
IMU	Change of Director's Interest Notice (CW)		30/10/15	135.25KB	Share
IMU	Ceasing to be a substantial holder		28/10/15	185.44KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	28/10/15	143.97KB	Share
IMU	Imugene Receives $755k R&D Tax Refund	PRICE SENSITIVE	28/10/15	116.37KB	Share
IMU	Appendix 3B and Section 708A Notice		26/10/15	344.75KB	Share
IMU	Letter to Option Holders		23/10/15	55.68KB	Share
IMU	Prospectus for Placement & Loyalty Options	PRICE SENSITIVE	23/10/15	2.45MB	Share
IMU	Appendix 3B - Loyalty Option Issue		23/10/15	292.37KB	Share
IMU	Results of Meeting		15/10/15	61.23KB	Share
IMU	AGM Corporate Presentation		15/10/15	6.58MB	Share
IMU	Imugene announces bonus options issue	PRICE SENSITIVE	13/10/15	40.75KB	Share
IMU	Notice of Annual General Meeting/Proxy Form		14/09/15	245.6KB	Share
IMU	Corporate Presentation		08/09/15	3.67MB	Share
IMU	Imugene Announces Successful Capital Raising	PRICE SENSITIVE	08/09/15	71.52KB	Share
IMU	Trading Halt	PRICE SENSITIVE	07/09/15	326.63KB	Share
IMU	Summary of Full Year Results		31/08/15	57.88KB	Share
IMU	Appendix 4G		31/08/15	83.27KB	Share
IMU	Appendix 4E and Annual Report 2015	PRICE SENSITIVE	31/08/15	1.57MB	Share
IMU	Immuno-oncology Specialist Appointed Chief Operating Officer		27/08/15	41.09KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/15	152.1KB	Share
IMU	Change of Share Registry		24/07/15	76.9KB	Share
IMU	New Research Note available from Edison Investment Research		13/07/15	70.58KB	Share
IMU	CRO Appointed to Conduct Phase 1b/2 Gastric Cancer Trial	PRICE SENSITIVE	01/07/15	106.09KB	Share
IMU	Proposed Issue of Options to Dr Axel Hoos		29/06/15	59.39KB	Share
IMU	Change of Share Registry Address		12/06/15	20.69KB	Share
IMU	Prof Ursula Wiedermann Appointed Chief Scientific Officer		05/06/15	47.15KB	Share
IMU	HER-Vaxx superior to Herceptin in tumour model	PRICE SENSITIVE	22/05/15	570.55KB	Share
IMU	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/15	152.22KB	Share
IMU	Imugene Files New HER-Vaxx Patent	PRICE SENSITIVE	21/04/15	62.06KB	Share
IMU	News Update and Corporate Presentation		20/04/15	12.68MB	Share
IMU	HER-Vaxx Re-Formulation Increases Efficacy Ten-Fold	PRICE SENSITIVE	20/04/15	75.2KB	Share
IMU	New Research Note available from Edison Investment Research		14/04/15	69.02KB	Share

IMU Investor Presentation
09/01/17		11.86MB	Share
IMU Investor Newsletter
20/12/16		10.13MB	Share
IMU Imugene progresses mimotope platform
19/12/16	PRICE SENSITIVE	239.63KB	Share
IMU Response to ASX Aware Query
16/12/16	PRICE SENSITIVE	202.23KB	Share
IMU Response to ASX Price Query
13/12/16	PRICE SENSITIVE	412.71KB	Share
IMU Acquisition of immuno-oncology technology
13/12/16	PRICE SENSITIVE	83.3KB	Share
IMU Imugene Corporate Presentation
02/12/16		7.35MB	Share
IMU Response to ASX Price Query
25/11/16	PRICE SENSITIVE	172.93KB	Share
IMU Leslie Chong Appointed Chief Executive Officer
21/11/16	PRICE SENSITIVE	174.4KB	Share
IMU Change of Director's Interest Notice
09/11/16		135.59KB	Share
IMU Change in substantial holding
07/11/16		144.93KB	Share
IMU Imugene Commences HER-Vaxx Phase 1b/2 Gastric Cancer Study
07/11/16	PRICE SENSITIVE	179.34KB	Share
IMU Ceasing to be a substantial holder
04/11/16		135.03KB	Share
IMU Appendix 3B, 708A Notice & Listing Rule 3.10.5A information-IMU.AX
03/11/16		370.49KB	Share
IMU Appendix 3B, 708A Notice & Listing Rule 3.10.5A information
03/11/16		370.49KB	Share
IMU Results of Meeting-IMU.AX
02/11/16		70.77KB	Share
IMU AGM Presentation-IMU.AX
02/11/16		1.4MB	Share
IMU Director Resignation - Final Director Interest Notice-IMU.AX
31/10/16		412.74KB	Share
IMU Becoming a substantial holder-IMU.AX
31/10/16		141.11KB	Share
IMU Appendix 4C - quarterly-IMU.AX
27/10/16	PRICE SENSITIVE	296.35KB	Share
IMU Appendix 3B-IMU.AX
27/10/16		290.29KB	Share
IMU Imugene Share Placement raises $3.2 million-IMU.AX
21/10/16	PRICE SENSITIVE	170.52KB	Share
IMU Trading Halt-IMU.AX
19/10/16	PRICE SENSITIVE	268.86KB	Share
IMU Notice of Annual General Meeting/Proxy Form-IMU.AX
30/09/16		1.04MB	Share
IMU Appendix 4G-IMU.AX
28/09/16		312.86KB	Share
IMU Annual Report to shareholders-IMU.AX
28/09/16		586.04KB	Share
IMU Imugene receives $1.3m R&D Tax Refund-IMU.AX
22/09/16	PRICE SENSITIVE	152.62KB	Share
IMU Imugene successfully completes preclinical animal studies-IMU.AX
20/09/16	PRICE SENSITIVE	56.94KB	Share
IMU Preliminary Final Report-IMU.AX
30/08/16	PRICE SENSITIVE	123.14KB	Share
IMU Imugene Final Cancer Vaccine Doses Delivered to GMP Depot-IMU.AX
30/08/16	PRICE SENSITIVE	61.47KB	Share
IMU Imugene Receives Approval to Start Gastric Cancer Study-IMU.AX
22/08/16	PRICE SENSITIVE	173.4KB	Share
IMU Imugene Receives Institutional Review Board approval-IMU.AX
11/08/16	PRICE SENSITIVE	44.54KB	Share
IMU Appendix 4C - quarterly-IMU.AX
29/07/16	PRICE SENSITIVE	392.39KB	Share
IMU Imugene Receives Institutional Review Board Approval-IMU.AX
11/07/16	PRICE SENSITIVE	268.17KB	Share
IMU Becoming a substantial holder-IMU.AX
06/07/16		309.56KB	Share
IMU Ceasing to be a substantial holder-IMU.AX
15/06/16		270.23KB	Share
IMU Corporate Development Update-IMU.AX
27/05/16		115.75KB	Share
IMU Appendix 4C - quarterly-IMU.AX
29/04/16	PRICE SENSITIVE	689.56KB	Share
IMU Regulatory package submission for Her-Vaxx in Hong Kong-IMU.AX
21/04/16	PRICE SENSITIVE	140.36KB	Share
IMU Shareholder Newsletter-IMU.AX
13/04/16		809.32KB	Share
IMU Dr Yelena Janjigian appointed as SAB member-IMU.AX
12/04/16		120.26KB	Share
IMU Manufacturing Update
07/03/16	PRICE SENSITIVE	50.79KB	Share
IMU Imugene Results for December Half Year
29/02/16		140.69KB	Share
IMU Half Yearly Report and Accounts
29/02/16	PRICE SENSITIVE	695.7KB	Share
IMU Imugene to present at the RedChip Global Online Conference
10/02/16		126.84KB	Share
IMU Appendix 4C - quarterly
27/01/16	PRICE SENSITIVE	153.95KB	Share
IMU Partnership to Develop Mimotope Immuno-Oncology Platform
20/01/16	PRICE SENSITIVE	56.12KB	Share
IMU Final Director's Interest Notice (OB)
18/01/16		35.16KB	Share
IMU Noble Financial Capital Markets Investor Presentation
15/01/16		197.88KB	Share
IMU Biotech Showcase Presentation
11/01/16		6.03MB	Share
IMU Initial Director's Interest Notice AU
07/01/16		235.15KB	Share
IMU Dr. Anton Uvarov appointed Non-Executive Director
05/01/16		117.38KB	Share
IMU Stuart Roberts named as Head of Corporate Development
04/01/16		49.97KB	Share
IMU Imugene to present at the 2016 Biotech Showcase
22/12/15		38.65KB	Share
IMU Imugene key HER-Vaxx patent granted in Europe
18/12/15	PRICE SENSITIVE	45.22KB	Share
IMU Director Resignation - Mr. Otto Buttula
17/12/15		110.9KB	Share
IMU Change of Director's Interest Notice (PH)
14/12/15		141.15KB	Share
IMU Novotech appointed Contract Research Organisation
14/12/15	PRICE SENSITIVE	48.37KB	Share
IMU Change of Director's Interest Notice (OB)
11/12/15		139.52KB	Share
IMU Change of Director's Interest Notice (PH)
08/12/15		141.52KB	Share
IMU Change of Director's Interest Notice (OB)
30/11/15		139.53KB	Share
IMU Change of Director's Interest Notice (OB)
23/11/15		140.16KB	Share
IMU Change of Director's Interest Notice (PH)
13/11/15		137.1KB	Share
IMU Change of Director's Interest Notice (OB)
13/11/15		136.62KB	Share
IMU Change of Director's Interest Notice (CW)
13/11/15		136.41KB	Share
IMU Appendix 3B
09/11/15		293.08KB	Share
IMU Change of Director's Interest Notice (AH)
02/11/15		139.98KB	Share
IMU Change of Director's Interest Notice (OB)
30/10/15		135.94KB	Share
IMU Change of Director's Interest Notice (CW)
30/10/15		135.25KB	Share
IMU Ceasing to be a substantial holder
28/10/15		185.44KB	Share
IMU Appendix 4C - quarterly
28/10/15	PRICE SENSITIVE	143.97KB	Share
IMU Imugene Receives $755k R&D Tax Refund
28/10/15	PRICE SENSITIVE	116.37KB	Share
IMU Appendix 3B and Section 708A Notice
26/10/15		344.75KB	Share
IMU Letter to Option Holders
23/10/15		55.68KB	Share
IMU Prospectus for Placement & Loyalty Options
23/10/15	PRICE SENSITIVE	2.45MB	Share
IMU Appendix 3B - Loyalty Option Issue
23/10/15		292.37KB	Share
IMU Results of Meeting
15/10/15		61.23KB	Share
IMU AGM Corporate Presentation
15/10/15		6.58MB	Share
IMU Imugene announces bonus options issue
13/10/15	PRICE SENSITIVE	40.75KB	Share
IMU Notice of Annual General Meeting/Proxy Form
14/09/15		245.6KB	Share
IMU Corporate Presentation
08/09/15		3.67MB	Share
IMU Imugene Announces Successful Capital Raising
08/09/15	PRICE SENSITIVE	71.52KB	Share
IMU Trading Halt
07/09/15	PRICE SENSITIVE	326.63KB	Share
IMU Summary of Full Year Results
31/08/15		57.88KB	Share
IMU Appendix 4G
31/08/15		83.27KB	Share
IMU Appendix 4E and Annual Report 2015
31/08/15	PRICE SENSITIVE	1.57MB	Share
IMU Immuno-oncology Specialist Appointed Chief Operating Officer
27/08/15		41.09KB	Share
IMU Appendix 4C - quarterly
30/07/15	PRICE SENSITIVE	152.1KB	Share
IMU Change of Share Registry
24/07/15		76.9KB	Share
IMU New Research Note available from Edison Investment Research
13/07/15		70.58KB	Share
IMU CRO Appointed to Conduct Phase 1b/2 Gastric Cancer Trial
01/07/15	PRICE SENSITIVE	106.09KB	Share
IMU Proposed Issue of Options to Dr Axel Hoos
29/06/15		59.39KB	Share
IMU Change of Share Registry Address
12/06/15		20.69KB	Share
IMU Prof Ursula Wiedermann Appointed Chief Scientific Officer
05/06/15		47.15KB	Share
IMU HER-Vaxx superior to Herceptin in tumour model
22/05/15	PRICE SENSITIVE	570.55KB	Share
IMU Appendix 4C - quarterly
29/04/15	PRICE SENSITIVE	152.22KB	Share
IMU Imugene Files New HER-Vaxx Patent
21/04/15	PRICE SENSITIVE	62.06KB	Share
IMU News Update and Corporate Presentation
20/04/15		12.68MB	Share
IMU HER-Vaxx Re-Formulation Increases Efficacy Ten-Fold
20/04/15	PRICE SENSITIVE	75.2KB	Share
IMU New Research Note available from Edison Investment Research
14/04/15		69.02KB	Share

REFRESH

First 7 8 9 10 11

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 26.5¢		Change -0.010(3.64%)		Mkt cap ! $76.45M

Open	High	Low	Value	Volume
27.0¢	27.5¢	26.0¢	$429.4K	1.618M

Buyers (Bids)

No.	Vol.	Price($)
17	433247	26.0¢

Sellers (Offers)

Price($)	Vol.	No.
26.5¢	28052	5

View Market Depth

No.	Vol.	Price($)
16	429401	0.260
18	332553	0.255
29	560028	0.250
10	87366	0.245
10	83374	0.240

Price($)	Vol.	No.
0.265	26303	2
0.270	23003	2
0.275	305890	9
0.280	122485	6
0.285	172137	7

Last trade - 16.10pm 08/08/2025 (20 minute delay)

IMU (ASX) Chart

IMUGENE LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available